
GuiZhou
603439.SSGuiZhou SanLi Pharmaceutical Co.,Ltd Price (603439.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
406,787,316
(0.1313)%Revenue and Profitability
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 159,326,147 | 266,877,706 | 359,041,885 | 514,609,248 | 638,331,037 | 722,346,117 | 883,782,738 | 630,224,958 | 938,966,120 | 1,201,316,448 | 1,634,977,930 |
Net Income | 19,372,953 | 28,994,187 | 52,610,072 | 74,879,741 | 87,628,188 | 110,482,525 | 133,081,547 | 93,952,848 | 152,282,553 | 201,284,234 | 292,702,869 |
FCF USD | 21,320,123 | -25,725,726 | -17,248,693 | 22,739,554 | 50,292,510 | 73,561,627 | 108,227,558 | 11,539,484 | 128,960,174 | 173,380,023 | 167,966,667 |
OCF USD | 30,085,682 | 563,457 | 33,277,907 | 35,099,300 | 57,465,617 | 75,346,532 | 116,238,181 | 63,247,318 | 155,037,459 | 293,285,899 | 276,701,402 |
Financial Health - DEBT
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.02 |
D/E | 0.45 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | 0.19 | 0.17 | 0.41 |
CA/CL | 1.35 | 1.39 | 2.18 | 5.00 | 5.31 | 8.45 | 8.34 | 3.49 | 3.05 | 2.14 | 1.78 |
TA/TL | 1.53 | 1.78 | 3.51 | 5.92 | 6.14 | 9.83 | 9.17 | 4.55 | 3.77 | 3.14 | 2.41 |
Total Debt | 31,000,000 | 60,600,000 | 0 | 0 | 0 | 0 | 0 | 200,000,000 | 200,000,000 | 205,668,805 | 609,958,581 |
Management Performance
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | 14.35% | 16.23% | 19.61% | 12.93% | 15.28% | 15.98% | 19.87% | 8.03% | 12.11% | 13.21% | 12.39% |
ROE | 28.04% | 26.62% | 24.30% | 17.39% | 18.51% | 21.33% | 20.44% | 9.57% | 14.76% | 16.25% | 19.91% |
ROA | 0.00% | 11.66% | 17.38% | 14.45% | 15.50% | 19.16% | 18.21% | 7.46% | 10.58% | 10.57% | 10.02% |
NM % | 12.16% | 10.86% | 14.65% | 14.55% | 13.73% | 15.29% | 15.06% | 14.91% | 16.22% | 16.76% | 17.90% |
FCF / R% | 0.00% | -9.64% | -4.80% | 4.42% | 7.88% | 10.18% | 12.25% | 1.83% | 13.73% | 14.43% | 10.27% |
FCF / NI% | 110.05% | -88.73% | -32.79% | 30.37% | 57.39% | 66.58% | 81.33% | 12.28% | 86.78% | 90.33% | 57.38% |
Operating Margin (OM) | 0.00 | 0.17 | 0.13 | 0.10 | 0.13 | 0.16 | 0.26 | 0.50 | 0.38 | 0.44 | 0.47 |
Per Share
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.06 | 0.09 | 0.17 | 0.22 | 0.24 | 0.30 | 0.33 | 0.23 | 0.37 | 0.49 | 0.72 |
SPS | 0.51 | 0.86 | 1.19 | 1.54 | 1.75 | 1.97 | 2.17 | 1.55 | 2.31 | 2.95 | 4.02 |
OCPS | 0.10 | 0.00 | 0.11 | 0.10 | 0.16 | 0.21 | 0.29 | 0.16 | 0.38 | 0.72 | 0.68 |
FCPS | 0.07 | -0.08 | -0.06 | 0.07 | 0.14 | 0.20 | 0.27 | 0.03 | 0.32 | 0.43 | 0.41 |
BVPS | 0.22 | 0.35 | 0.72 | 1.29 | 1.30 | 1.41 | 1.60 | 2.41 | 2.53 | 3.04 | 4.20 |
Per Share - CAGR
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.06 | 0.09 | 0.17 | 0.22 | 0.24 | 0.30 | 0.33 | 0.23 | 0.37 | 0.49 | 0.72 |
CAGR-SPS | 0.51 | 0.86 | 1.19 | 1.54 | 1.75 | 1.97 | 2.17 | 1.55 | 2.31 | 2.95 | 4.02 |
CAGR-OCPS | 0.10 | 0.00 | 0.11 | 0.10 | 0.16 | 0.21 | 0.29 | 0.16 | 0.38 | 0.72 | 0.68 |
CAGR-FCPS | 0.07 | -0.08 | -0.06 | 0.07 | 0.14 | 0.20 | 0.27 | 0.03 | 0.32 | 0.43 | 0.41 |
CAGR-BVPS | 0.22 | 0.35 | 0.72 | 1.29 | 1.30 | 1.41 | 1.60 | 2.41 | 2.53 | 3.04 | 4.20 |